Tag: access to healthcare

Advocating for the addition of MS treatments to the WHO Essential Medicines List

As the year draws to a close, MSIF reflects on 2024 and looks ahead to the future.

Many people with MS experience delays in diagnosis and are often misdiagnosed. Consider what can be done to improve awareness and improve early diagnosis.

After 18 years of dedicated service Peer Baneke, the Chief Executive of MSIF, will be retiring this December.

The MS Society of India’s online campaign for better MS insurance coverage

"Siempre tenemos la esperanza de que las cosas mejoren en el futuro y de que, algún día, consigamos encontrar una cura definitiva para la esclerosis múltiple. Hasta entonces, tenemos que seguir las investigaciones más recientes".

MSIF Du Pré grants support the development of MS healthcare expertise

A 10-year global action plan that aims to improve the lives of people living with neurological conditions including MS

New publication highlights regional disparities in the management of MS

MS organisations across MENA use their collective voice to advocate for safe and effective MS treatment in a new regional charter

New research explores challenges around MS management in the region.

Collaborating with the Medicines Patent Pool as MSIF continues work on improving access to MS treatments

Addressing barriers to accessing MS healthcare at a global, regional and national level.

'To even get my diagnosis I had to borrow money from others.'

'I keep worrying: What if I was unable to get my treatment for a month or so? What will be the consequences?'

'I felt down, empty and lonely when I couldn’t go to the school.'

‘I don't count how many times I fall. I count how many times I stand up.’

‘She went to sleep and didn’t wake up for two months’

‘They said ‘if a car is broken, it is useless to repair a tyre when the major problem is the engine’

‘I actually want to be in a more corporate kind of role in which you would be married to your job a bit more. That excites me.’

Provide information on the number of people with MS and barriers to accessing healthcare to key decision-makers in your country.

Multiple Sclerosis (MS) treatments added to WHO’s Essential Medicines List for the first time

Advocacy examples from the global MS movement to inspire you today.

'I was left in a situation of being newly diagnosed, scared and with the prospect that I didn't have health coverage.'

Your guide to successful advocacy. Tools and resources for healthcare professionals, MS organisations and people affected by MS to support their advocacy efforts to improve access to MS healthcare.